Star Health and Allied Insurance's Rs 7,250-crore initial public offering (IPO), the third largest this year and eighth largest ever, just about managed to make it despite a poor response from investors, garnering just 79 per cent subscription, forcing the investment bankers to prune offer for sale (OFS) component. This is the second large offering after digital payments major Paytm this year to receive a lukewarm response from investors, a sign that despite the IPO frenzy investors are discerning when it comes to pricing. As Star Health didn't meet the profitability criteria, its IPO required a mandatory 75 per cent subscription from qualified institutional buyers (QIB).
As its factories resumed operations after over two-month of grim battle against coronavirus, China is busy tapping into the vast business opportunities of export of key medical goods, specially ventilators and personal protection equipment (PPE), across the world, including India, where both private and government bodies are placing orders for the import of these products.
The Maharashtra Anti-Terrorism Squad (ATS) on Monday took an accused arrested in the Mansukh Hiran murder case to the creek where his body was found, and also detained a person from Gujarat who had provided them SIM cards, officials said.
The scene was recreated late on Friday night, in which Waze was asked to walk there for some time wearing a white kurta.
Maharashtra Home Minister Anil Deshmukh said on Wednesday that police officer Sachin Vaze will be removed from the Crime Branch and posted in some other department.
The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of Rs 2,465 crore. This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise Rs 18,243 crore. So far in the current fiscal, a total of 20 companies have mopped up more than Rs 45,000 crore through IPOs. This is much higher than Rs 31,277 crore raised by 30 firms in the entire 2020-21.
'EV-charging is the next big opportunity after fuelling'
India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi.
Indian auto and pharma industries import several critical components and raw materials from China.
FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms.
Engineering graduates specialising in artificial intelligence and machine learning can earn up to 24 lakh a year, says Saran Balasundaram, founder and CEO, HanDigital, a talent consulting firm.
However, masters degree with National Eligibility Test or PhD would continue to be the minimum eligibility criterion for direct recruitment in colleges, a senior official said.
Raut said the MVA government in did not have damage control machinery.
The Union government is keen to ensure financial security for unorganised sector workers
Can Interferon alfa-2b treat COVID-19 effectively?
Three stockmarket experts give their best picks for the New Year.
'There will be partnerships between banks and fintech firms, but there will also be areas where they will be direct competitors.'
Former Mumbai Police Commissioner Param Bir Singh, whose allegations against Maharashtra Home Minister Anil Deshmukh have created a political storm in the state, wrote a letter to the chief minister as he was hurt over remarks of Deshmukh and it was a matter relating to his 'self-respect', sources close to him have said.
Anil Rego, CEO, Right Horizons, answers your personal income tax queries.
Dr Reddy's gets warning from US health regulator
Poornima Indrajith, who acted with Nedumudi Venu in the daily soap Oomakkuyil for three years, shares lovely memories of the legendary actor, who passed into the ages on October 11.
By the time the security failure is discovered and fixed, the damage is already done. A CIO survey by Forcepoint and Frost & Sullivan found that 69 per cent of Indian organisations were at risk of data breach. Whenever there is data breach, there is a potential disaster waiting to happen.
Anil Rego, CEO, Right Horizons, answers your personal income tax queries
The social media giant had been under scanner lately for the growing online data-privacy concerns.
'Q1 is going to bear the brunt of the second wave, exposing full-year GDP forecasts to downward revisions, unless phase-3 of vaccination is executed quickly.'
The meeting will review annual financial performance of public sector banks, credit offtake in the economy, priority sector lending and progress made under various social sector schemes, including Atal Pension Yojana (APY) and Pradhan Mantri Jan Dhan Yojana.
The Supreme Court on Wednesday dismissed a plea by former Maharashtra home minister Anil Deshmukh seeking to quash the FIR lodged against him by the Central Bureau of Investigation in a corruption case.
Skylark Drones, a leading drone platform company that counts Tata Steel, Ultratech Cement, Softbank Energy among its customers has secured $3 million in a pre-series A funding round. It would use the funding to strengthen its product offerings and fuel international expansion.
Singh on Saturday claimed Deshmukh wanted police officers to collect Rs 100 crore monthly from bars and hotels.
The former police chief also said that the Home Minister had on several occasions instructed police officers on how to handle cases and file charges.
As per the clinical trial protocol approved, 150 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care. Treatment duration is a maximum of 14 days and the total study duration will be a maximum for 28 days from randomisation.
Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.
'My wife, who expresses her fears and anxieties every night when I return home after doing my duty at a COVID-19 containment zone, promptly wakes me up the next morning so that I can report for duty on time.'
"It is a serious matter. The home minister should resign, the Maharashtra government should resign and there should be a CBI inquiry into the whole issue'
The recovered some "incriminating" documents and electronic evidence such as laptop, I-pad and mobile phones from Waze's office there, the official said.
After a long wait, the Shapoorji Pallonji Group has closed the sale process of its consumer durables business under the Eureka Forbes label by picking the American private equity fund Advent International's Rs 4,400-crore offer for a 72 per cent stake. The sale process, which began in November 2019, will help the over 156-year-old SP Group pair the debt pile and sharpen the focus on the flagship construction and engineering business under Afcons. The valuation of Rs 4,400 crore for a 72.56 per cent stake is is at an enterprise level and subject to closing adjustments and also includes an open offer for the remaining stake after the demerger and listing of Eureka Forbes, the SP group said in a statement on Sunday.
The fees for facility inspection of foreign companies have been reduced
Local land records also say the land at Kalapani and Lipulekh belongs to the residents of two villages on the Indian side of the border, an official recently said.
Ranbaxy Laboratories Ltd said on Monday it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing and marketing of Active Pharmaceutical Ingredient and formulations containing anti-HIV drug Tenofovir.
In a notice to the stock exchanges a few days ago, DLF declared that it was going to consider international acquisitions and investments in development projects abroad. Ansals API tied up with Malaysia's UEM Group to form a 60:40 joint venture company, Ansal Api-UEM Contracts Pvt Ltd, which could bid for government projects in Malaysia, as also projects worldwide.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances